BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23547578)

  • 21. Dermatofibrosarcoma protuberans.
    Miller SJ; Alam M; Andersen J; Berg D; Bichakjian CK; Bowen G; Cheney RT; Glass F; Grekin RC; Grichnik JM; Kessinger A; Lee NY; Lessin S; Lydiatt DD; Margolis LW; Michalski J; Nehal KS; Nghiem P; Oseroff AR; Rosenberg EW; Shaha AR; Siegle RJ; Urist MM;
    J Natl Compr Canc Netw; 2007 May; 5(5):550-5. PubMed ID: 17509257
    [No Abstract]   [Full Text] [Related]  

  • 22. [New molecular approaches in dermatofibrosarcoma protuberans].
    Kaya G
    Rev Med Suisse; 2009 Jul; 5(211):1519-24. PubMed ID: 19694363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent giant cell fibroblastoma treated with Mohs micrographic surgery.
    Najarian DJ; Morrison C; Sait SN; Meguerditchian AN; Kane J; Cheney R; Zeitouni NC
    Dermatol Surg; 2010 Mar; 36(3):417-21. PubMed ID: 20100251
    [No Abstract]   [Full Text] [Related]  

  • 24. Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients.
    Nelson RA; Arlette JP
    Ann Plast Surg; 2008 Jun; 60(6):667-72. PubMed ID: 18520205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual cutaneous malignancies.
    Cook TF; Fosko SW
    Semin Cutan Med Surg; 1998 Jun; 17(2):114-32. PubMed ID: 9669605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
    Savoia P; Ortoncelli M; Quaglino P; Bernengo MG
    Dermatol Surg; 2006 Aug; 32(8):1097-102. PubMed ID: 16918576
    [No Abstract]   [Full Text] [Related]  

  • 27. Dermatofibrosarcoma protuberans.
    Dimitropoulos VA
    Dermatol Ther; 2008; 21(6):428-32. PubMed ID: 19076619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.
    Mizutani K; Tamada Y; Hara K; Tsuzuki T; Saeki H; Tamaki K; Matsumoto Y
    Br J Dermatol; 2004 Jul; 151(1):235-7. PubMed ID: 15270901
    [No Abstract]   [Full Text] [Related]  

  • 29. True Mohs or not true Mohs, that is really the question.
    Stigall LE; Brodland DG
    J Plast Reconstr Aesthet Surg; 2014 Sep; 67(9):1296-7. PubMed ID: 24838068
    [No Abstract]   [Full Text] [Related]  

  • 30. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins.
    Dawes KW; Hanke CW
    Dermatol Surg; 1996 Jun; 22(6):530-4. PubMed ID: 8646467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidisciplinary approach to the management of dermatofibrosarcoma protuberans.
    Buck DW; Kim JY; Alam M; Rawlani V; Johnson S; Connor CM; Dumanian GA; Wayne JD
    J Am Acad Dermatol; 2012 Nov; 67(5):861-6. PubMed ID: 22387033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncommon cutaneous neoplasms.
    Harrington AC; Freitag DS
    Md Med J; 1997; 46(5):255-62. PubMed ID: 9159057
    [No Abstract]   [Full Text] [Related]  

  • 33. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatofibrosarcoma protuberans: dealing with slow Mohs procedures employing formalin-fixed, paraffin wax-embedded tissue in a busy diagnostic laboratory.
    Orchard GE; Shams M
    Br J Biomed Sci; 2012; 69(2):56-61. PubMed ID: 22872928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dermatofibrosarcoma protuberans of Darier and Ferranda study of 28 cases in adult].
    Sana T; Bécima F; Rachida Z; Olfa K; Faten Z; Nadia el F; Insaf M; Sarrah BJ; Mohamed-Ridha K
    Tunis Med; 2005 Aug; 83(8):457-62. PubMed ID: 16238272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans.
    Meguerditchian AN; Wang J; Lema B; Kraybill WG; Zeitouni NC; Kane JM
    Am J Clin Oncol; 2010 Jun; 33(3):300-3. PubMed ID: 19858696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonmelanoma skin cancer.
    Lee DA; Miller SJ
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):309-24. PubMed ID: 19698913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
    Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
    Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumor modeling and a review of cases treated with Mohs micrographic surgery.
    Haycox CL; Odland PB; Olbricht SM; Casey B
    Ann Plast Surg; 1997 Mar; 38(3):246-51. PubMed ID: 9088462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guess what. Dermatofibrosarcoma protuberans presenting as an atrophic red plaque.
    See AC; Kossard SS; Murrell DF
    Eur J Dermatol; 2001; 11(2):147-9. PubMed ID: 11275815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.